The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts - Bertin Instruments

    Scientific publications

    The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts

    Angela C. Hirbea, a, Anke J. Roelofsc, c, Desiree H. Floyda, a, Hongju Denga, a, Stephanie N. Beckera, a, Lisa G. Lanigand, d, Anthony J. Apicellia, a, Zhiqiang Xua, a, Julie L. Priorb, b, Mark C. Eagletona, a, David Piwnica-Wormsb, b, Michael J. Rogersc, 12 and Katherine Weilbaechera, a, mailto:kweilbae@im.wustl.edumailto:kweilbae@im.wustl.edu
    Sources: a Department of Medicine, Division of Molecular Oncology, Washington University School of Medicine, 660 S. Euclid, Box 8069, St. Louis, MO 63110, USAb Molecular Imaging Center, Department of Radiology, Washington University School of Medicine, St. Louis, MO, 63110, USAc Bone and Musculoskeletal Research Programme, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotlandd Department of Veterinary Biosciences, College of Veterinary Medicine, Ohio State University, Columbus, OH, USA
    BoneVolume 44, Issue 5, May 2009, Pages 908-916

    Sample name

    Animal tissues (ear, tail, hip, foot)

    ANY QUESTIONS? CONTACT AN EXPERT

    Please fill in this form if you wish to contact our sales team or receive further information.

    My Account
    Forgot password ?

    Add a question !

    Add a question